| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.7M | — | +87.2% |
| Cost of Revenue | $4.8M | — | +0.4% |
| Gross Profit | $6.9M | — | +361.1% |
| R&D Expense | $8.6M | — | +18.0% |
| SG&A Expense | $30.2M | — | +292.2% |
| Operating Income | -$31.8M | — | -136.1% |
| Interest Expense | $1.2M | — | -16.6% |
| Income Tax | $0 | — | — |
| Net Income | -$32.3M | — | -126.8% |
| EPS (Basic) | -$0.71 | — | -3450.0% |
| EPS (Diluted) | -$0.71 | — | -3450.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $29.6M | -26.4% | -24.7% |
| Short-term Investments | $34.7M | -35.5% | +39.2% |
| Accounts Receivable | $14.7M | +21.4% | +225.1% |
| Inventory | $8.3M | +23.9% | +84.2% |
| Current Assets | $92.3M | -21.5% | +17.7% |
| Total Assets | $102.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$32.0M | — | -99.2% |
| Capital Expenditures | $111K | — | -74.4% |
| Investing Cash Flow | $18.0M | — | +171.1% |
| Financing Cash Flow | $3.4M | — | -44.3% |
| Free Cash Flow | -$32.1M | — | -94.6% |
| +17.9% |
| Current Liabilities | $26.3M | +8.1% | +131.2% |
| Long-term Debt | $35.9M | +0.9% | +2.7% |
| Total Liabilities | $68.5M | +5.1% | +31.7% |
| Stockholders' Equity | $34.3M | -43.8% | -2.4% |